In the past year, our laboratory has become interested in the molecular mechanisms responsible for transcriptional regulation in the adipose cell and the molecular biology of the regulation of energy expenditure and of obesity. Our initial focus has been on a newly discovered hormone, leptin. Leptin is made in adipose cells and is important in the response to starvation and in feedback regulation of energy expenditure and adiposity. Mice homozygous for a nonfunctional leptin (previously denoted obese) or leptin receptor (previously denoted diabetes) gene become massively obese and develop diabetes mellitus due to overeating and decreased metabolic expenditure. Our goal is an understanding of the signals controlling transcription of the leptin gene. One line of investigation has been a detailed characterization of the leptin promoter, defining its structure and then studying protein-DNA ubteractions and their functional implications using transient expression. We have defined C/EBP, Sp1- like, and TATA sequence elements in the promoter, shown cognate factor binding, and demonstrated their functional contribution to transcription. A complimentary approach has been examination of the regulation of leptin in intact adipose cells. Our plan is that the studies of endogenous gene expression will converge with the promoter characterization work, leading to elucidation of the machanistic details. Out of a number of hormones tested, glucocordicoids specifically and selectively increased transcription of the endogenous leptin gene and were selected for further characterization. This result is consistent with the observation of elevated leptin levels in patients with Cushing's syndrome. In the past year we have begun generating genetically modified mice expected to have defects in adipose cell biology and in energy metabolism. These long-term studies will allow us to take the detailed knowledge of hormonal and promoter regulation and apply it in the complete organism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK047031-05
Application #
2573454
Study Section
Special Emphasis Panel (DB)
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1996
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Yamauchi, T; Kamon, J; Waki, H et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-6
Ebihara, K; Ogawa, Y; Masuzaki, H et al. (2001) Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes 50:1440-8
Reitman, M L; Bi, S; Marcus-Samuels, B et al. (2001) Leptin and its role in pregnancy and fetal development--an overview. Biochem Soc Trans 29:68-72
Tansey, J T; Sztalryd, C; Gruia-Gray, J et al. (2001) Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A 98:6494-9
Deng, J; St Clair, M; Everett, C et al. (2000) Buprenorphine given after surgery does not alter renal ischemia/reperfusion injury. Comp Med 50:628-32
Gong, D W; Monemdjou, S; Gavrilova, O et al. (2000) Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J Biol Chem 275:16251-7
Gavrilova, O; Marcus-Samuels, B; Graham, D et al. (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 105:271-8
Reitman, M L; Arioglu, E; Gavrilova, O et al. (2000) Lipoatrophy revisited. Trends Endocrinol Metab 11:410-6
Arioglu, E; Duncan-Morin, J; Sebring, N et al. (2000) Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes. Ann Intern Med 133:263-74
Kim, J K; Gavrilova, O; Chen, Y et al. (2000) Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem 275:8456-60

Showing the most recent 10 out of 21 publications